A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Q&A: Large-scale commercial expansion at Lonza’s Stein facility - Fierce Pharma
Q&A: Large-scale commercial expansion at Lonza’s Stein facility Fierce Pharma
Lonza to Acquire Redberry SAS - Contract Pharma
Lonza to Acquire Redberry SAS Contract Pharma
Lonza's recently purchased Calif. biologics site plays key role in sales rebound - Fierce Pharma
Lonza's recently purchased Calif. biologics site plays key role in sales rebound Fierce Pharma
Lonza Completes New Drug Product Filling Line in Stein, Switzerland - Contract Pharma
Lonza Completes New Drug Product Filling Line in Stein, Switzerland Contract Pharma
Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma
Lonza Expands Cell and Gene Therapy Portfolio Contract Pharma
Lonza’s Synaffix and Qurient team up on dual-payload ADC - The Pharma Letter
Lonza’s Synaffix and Qurient team up on dual-payload ADC The Pharma Letter
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing Contract Pharma
Lonza Appoints Jason Berndt as Head of Group Operations - Contract Pharma
Lonza Appoints Jason Berndt as Head of Group Operations Contract Pharma
Executive changes at Lonza - The Pharma Letter
Executive changes at Lonza The Pharma Letter
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
Lonza lifts forecast as performance rebounds under new strategy The Pharma Letter
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling Fierce Pharma
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical Technology
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
Ethris and Lonza focus on mRNA respiratory condition vaccines Pharmaceutical Technology
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines Contract Pharma
Lonza Implements Streamlined Operating Model - Contract Pharma
Lonza Implements Streamlined Operating Model Contract Pharma
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 Contract Pharma
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market Fierce Pharma
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page